GL1X · GenesisL1 explorer

MolNFT v1 · #135242 · protein

Discovery of tak-659, an orally available investigational inhibitor of spleen tyrosine kinase (syk)

5TT7 · Tyrosine-protein kinase syk: “Discovery of tak-659, an orally available investigational inhibitor of spleen tyrosine kinase (syk)”. X-ray diffraction, 1 ligand (7KF), 2 pockets (best druggability 0.57). MolNFT v1 #135242 on…

PDB
5TT7
Type
protein
Length
274 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase syk
EC
2.7.10.2
UniProt
P43405
Ligands
7KF
Pockets
2 · best druggability 0.57

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase syk (EC 2.7.10.2)protein27442% helix, 19% strandP43405

Ligands and binding sites

  • 7KF · 2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-5-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12620.570.77297KF
2750.320.7420empty

Compared structures

  • 5TT7 · Discovery of TAK-659, an Orally Available Investigational Inhibitor of Spleen Tyrosine… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.